Table 4 Unadjusted and adjusted Odds ratios (OR) of ESBLs, AmpC and MDR by participants characteristics

Age

 0–14

1.0

1.0

 15–44

1.65 (1.22, 2.23)^a

6.49 (0.91, 46.16)

 45+

1.38 (0.90, 2.12)

1.89 (0.21, 16.75)

Sex

 Female

1.0

1.0

 Male

1.52 (0.88, 2.63)

1.51 (0.76, 2.97)

HC level

 NR

1.0

1.0

1.0

1.0

 GH

1.65 (0.35, 7.8)

0.89 (0.15, 5.28)

0.32 (0.20, 0.52)^a

0.18 (0.001, 27.32)

 HCIV

0.53 (0.07, 3.98)

0.31 (0.03, 2.88)

0.27 (0.16, 0.46)^a

1.96 (0.01, 491.00)

 HCIII

–

–

0.21 (0.13, 0.33)^a

2.59 (0.02, 331.66)

District

 Kampala

1.0

1.0

 Kayunga

0.17 (0.12, 0.24)^a

0.02 (0.00, 3.54)

 Mpigi

0.20 (0.14, 0.28)^a

0.36 (0.003, 38.44)

HSD

 Cases >100

1.0

1.0

1.0

1.0

 Cases <100

6.77 (0.81, 56.94)

6.71 (0.46, 97.96)

1.75 (1.33, 2.29)^a

0.13 (0.001, 12.37)

Reason for visit

 ISS

1.0

1.0

 Infection

1.38 (0.44, 4.35)

1.72 (0.47, 6.35)

 General

3.42 (1.05, 11.12)^a

4.38 (1.14, 16.84)^a

History of admission

 Yes

2.76 (1.12, 6.84)^a

2.92 (0.95, 9.02)

History of medical procedures

 Contact

1.0

1.0

 Inoculation

4.11 (0.45, 37.69)

50.76 (1.80, 1432.98)^a

 Surgery

0.83 (0.06, 11.42)

2.48 (0.06, 99.30)

 Antibiotic use

  Yes

4.47 (1.15, 17.44)^a

4.57 (0.90, 23.20)

0.79 (0.58, 1.07)^a

 Use of gentamicin

  Yes

0.27 (0.05, 1.32)

0.17 (0.03, 0.95)^a

 Use of ciprofloxacin

  Yes

1.52 (0.96, 2.40)^a

5.71 (0.69, 47.01)

 Use of septrin

  Yes

4.33 (0.84, 22.47)

4.70 (0.33, 66.82)

0.53 (0.40, 0.71)^a

1.92 (0.45, 8.23)